We are live on ! Find out more
DOFI

DCVC Opportunity Fund II Portfolio holdings

AUM $13.9M
1-Year Est. Return 8.04%
This Fund
S&P 500
This Quarter Est. Return
-26.29%
1 Year Est. Return
+8.04%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$13.9M
AUM Growth
-$2.72M
Cap. Flow
+$1.95M
Cap. Flow %
14.03%
Top 10 Hldgs %
100%
Holding
2
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
IONQ icon
IonQ
IONQ
+$1.95M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 87.48%
2 Technology 12.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXRX icon
1
Recursion Pharmaceuticals
RXRX
$1.56B
$12.1M 87.48%
3,951,141
IONQ icon
2
IonQ
IONQ
$13B
$1.74M 12.52%
60,226
+50,705
+533% +$1.95M

Similar funds

DCVC Opportunity Fund II's Q1 2026 Portfolio in Review

As of Q1 2026, DCVC Opportunity Fund II held 2 positions worth $13.9M, down 16% from $16.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

DCVC Opportunity Fund II deployed $1.95M of net new capital in Q1 2026, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, down from 97% a quarter earlier, followed by Technology.

  • DCVC Opportunity Fund II added most to IonQ in Q1 2026, an estimated $1.95M increase.
  • DCVC Opportunity Fund II's ten largest holdings make up 100% of its $13.9M portfolio in Q1 2026.
  • DCVC Opportunity Fund II opened 0 new positions and closed 0 in Q1 2026.
  • DCVC Opportunity Fund II's portfolio value fell 16% quarter-over-quarter to $13.9M.

Based on DCVC Opportunity Fund II's 13F filing for Q1 2026, filed 15 May 2026.